| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022428A1 Remedy for diabetes |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022338A1 Dry powder of pseudo leaf tissue of plant belonging to the genus asparagus |
| 03/02/2006 | WO2006022281A1 Preventive and remedy for collagen or elastin metabolic disorder |
| 03/02/2006 | WO2006022249A1 Target nucleic acid of retrovirus integration |
| 03/02/2006 | WO2006022237A1 Medicament for preventing or treating fatty liver |
| 03/02/2006 | WO2006022234A1 NFATc1 EXPRESSION INHIBITOR, OSTEOCLAST DIFFERENTIATION OR ACTIVATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION |
| 03/02/2006 | WO2006022227A1 Lipase inhibitor |
| 03/02/2006 | WO2006022187A1 Coenzyme q10-containing composition |
| 03/02/2006 | WO2006022173A1 HUMECTANT CONTAINING α-GLYCOSYL GLYCYRRHIZIN AS ACTIVE INGREDIENT AND USE THEREOF |
| 03/02/2006 | WO2006021888A2 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 03/02/2006 | WO2006021883A2 Ventilation system and device for shoes |
| 03/02/2006 | WO2006021881A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 03/02/2006 | WO2006021848A1 Anti-inflammatory agents |
| 03/02/2006 | WO2006021811A2 Treatment of posterior capsule opacification |
| 03/02/2006 | WO2006021744A1 Treatment of myocardial infarction with 11hsd1 inhibitors |
| 03/02/2006 | WO2006021692A1 Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 03/02/2006 | WO2006021660A1 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 03/02/2006 | WO2006021657A1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 03/02/2006 | WO2006021656A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/02/2006 | WO2006021655A2 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 03/02/2006 | WO2006021654A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 03/02/2006 | WO2006021653A2 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 03/02/2006 | WO2006021647A1 Use of a fatty acid for preparing a topical composition for allaying inflammatory reactions due to venemous hymenoptera stings |
| 03/02/2006 | WO2006021565A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021564A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021548A1 Dihydropteridinones, method for the production thereof, and use thereof as a medicament |
| 03/02/2006 | WO2006021547A1 Pteridinones used as plk (polo like kinase) inhibitors |
| 03/02/2006 | WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors |
| 03/02/2006 | WO2006021533A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 03/02/2006 | WO2006021456A1 Combination comprising a staurosporine and a cyp3a4 inhibitor |
| 03/02/2006 | WO2006021454A2 Pyrimidine derivatives |
| 03/02/2006 | WO2006021448A1 Novel compounds having an anti-bacterial activity |
| 03/02/2006 | WO2006021443A2 Composition comprising an at1 receptor blocker and a macrolide t-cell immunomodulator |
| 03/02/2006 | WO2006021441A1 Biphenyl-carboxylic acids and derivatives thereof and their use in therapy |
| 03/02/2006 | WO2006021425A1 Sustained release pharmaceutical composition of tolterodine |
| 03/02/2006 | WO2006021418A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | WO2006021412A2 Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| 03/02/2006 | WO2006021379A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | WO2006021378A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | WO2006021326A1 Process and intermediates for the selective synthesis of fluvastatin |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | WO2006021166A1 Procaine combination therapy |
| 03/02/2006 | WO2006010423A3 Azaindole inhibitors of mtp and apob |
| 03/02/2006 | WO2006006933A3 Antiproliferative compositions comprising aryl substituted xylopyranoside derivatives |
| 03/02/2006 | WO2006004449A3 A combination composition |
| 03/02/2006 | WO2006002121A3 Compounds and methods for treating seizure and paroxysmal disorders |
| 03/02/2006 | WO2006000324A3 New mao-b inhibitors |
| 03/02/2006 | WO2005123679A3 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2005123193A3 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
| 03/02/2006 | WO2005121148A3 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams |
| 03/02/2006 | WO2005120477A3 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 03/02/2006 | WO2005117858A3 Compositions comprising nebivolol |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | WO2005113018A3 Cancer treatment using viruses and camptothecins |
| 03/02/2006 | WO2005107717A8 Oral dosage form for the extended release of biguanide and sulfonylurea |
| 03/02/2006 | WO2005105072A3 Antifungal drug delivery |
| 03/02/2006 | WO2005101838A3 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005094799A3 Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity |
| 03/02/2006 | WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
| 03/02/2006 | WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| 03/02/2006 | WO2005092305A3 Compounds for treating aids and other diseases |
| 03/02/2006 | WO2005090603A3 Method for diagnosing non-small cell lung cancer |
| 03/02/2006 | WO2005089872A3 Treatment of local pain |
| 03/02/2006 | WO2005089730A3 Dna pkinase inhibitors for treating cancer and diabetes |
| 03/02/2006 | WO2005086763A3 Stable injectable compositions |
| 03/02/2006 | WO2005081752A3 Nitric oxide-releasing polymers |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | WO2005077056A3 Methods and compositions for the treatment of inflammation |
| 03/02/2006 | WO2005072388A3 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 03/02/2006 | WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 03/02/2006 | WO2005070827A3 Fullerene based amino acids |
| 03/02/2006 | WO2005058287A3 Transdermal delivery system of hormones without penetration enhancers |
| 03/02/2006 | WO2005051331A3 Chaperone-based therapy for niemann-pick disease |
| 03/02/2006 | WO2005051293A3 Methods and reagents for the treatment of inflammatory disorders |
| 03/02/2006 | WO2005046667A3 System a transport inhibitors for treating or preventing neuropsychiatric disorders |
| 03/02/2006 | WO2005045038A3 RNA interference mediated inhibition of GPRA and AAA1 gene expression using short nucleic acid (siNA) |
| 03/02/2006 | WO2005045036A3 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina) |
| 03/02/2006 | WO2005045032A3 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/02/2006 | WO2005027843A3 Chronotherapeutic dosage forms |
| 03/02/2006 | WO2005026184A9 Synthesis and compositions of 2'-terminator nucleotides |
| 03/02/2006 | WO2005023253A8 Use of pde4 inhibitors for the treatment of diabetes mellitus |
| 03/02/2006 | WO2005013948A3 Method of treating acute myocardial infarction |
| 03/02/2006 | WO2005009989A8 Nicotinamide derivatives useful as pde4 inhibitors |
| 03/02/2006 | WO2005009407A3 Oral pharmaceutical formulations of olanzapine |
| 03/02/2006 | WO2004110423A8 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine |
| 03/02/2006 | WO2004100871A3 Combination of an aldosterone receptor antagonist and a renin inhibitor |
| 03/02/2006 | WO2004052850A3 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 03/02/2006 | WO2004046331A3 2’-branched nucleosides and flaviviridae mutation |
| 03/02/2006 | WO2004032869A3 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 03/02/2006 | WO2003090686A3 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 03/02/2006 | WO2003082208A3 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | US20060047171 Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof |
| 03/02/2006 | US20060047119 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |